期刊文献+

侵袭性肺曲霉病动物模型的研究进展 被引量:2

Research progress on animal model of invasive pulmonary aspergillosis
原文传递
导出
摘要 近20年来,随着广谱抗生素、糖皮质激素、放疗、化疗的广泛应用,烧伤、器官移植、血液透析、肠外营养人数的增加以及艾滋病的流行等,侵袭性肺曲霉病的发病率日益增加。随着侵袭性肺曲霉病的发病机制以及早期诊断等相关研究不断深入,相关研究需建立在成功的动物模型基础上,所以动物模型的建立具有重要意义。本文对近几年肺曲霉病的动物模型研究作一综述。 In recent twenty years, with the extensive use of broad-spectrum antibiotics, cortieosteroids, radiotherapy, chemotherapy, the increase of burns, organ transplantation, hemodialysis, parenteral nutrition, and the prevalence of acquired immune deficiency syndrome, the morbidity of invasive pulmonary aspergillosis is increasing. With the deep researches on mechanism and early diagnosi,~ of invasive pulmonary aspergillosis, relevant research should be based on successful animal model, so the animal model is important. This article summaries the researches about animal model of pulmonary aspergillosis in recent years.
出处 《国际呼吸杂志》 2011年第6期468-470,共3页 International Journal of Respiration
关键词 侵袭性肺曲霉病 动物模型 Invasive pulmonary aspergillosis Animal model
  • 相关文献

参考文献16

  • 1Tomee JF, van der Werf TS. Pulmonary aspergillosis. Neth J Med,2001,59:244-258. 被引量:1
  • 2Soubani AO, Chandrasekar PH. The clinical spectrum of puhnonary aspergillosis. Chest, 2002,121:1988-1999. 被引量:1
  • 3Singh N, Paterson DI.. Aspergillus infections in transplant recipients. Clin Microbiol Rev, 2005,18 : 44-69. 被引量:1
  • 4Marr KA, Carter RA, Crippa F, et al. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis, 2002,34:909-917. 被引量:1
  • 5Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med, 2002,347 : 408-415. 被引量:1
  • 6李振.恶性肿瘤的化学治疗与免疫治疗[M].北京:人民卫生出版社,1998.44-46. 被引量:9
  • 7赵弋清,罗霞,陈东辉,余梦瑶,杨志荣.不同剂量环磷酰胺诱导正常小鼠免疫抑制的对比研究[J].免疫学杂志,2005,21(B06):122-124. 被引量:82
  • 8杨颖,蔡玟,黄志彪,黄俊明,李文立,黄健康.环磷酰胺致小鼠免疫功能低下模型建立与评价[J].中国公共卫生,2008,24(5):581-583. 被引量:47
  • 9Balloy V, Huerre M, Latge JP,et al. Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental aspergillosis. Infect Immun, 2005,73. 被引量:1
  • 10Chiang LY, Sheppard DC, Gravelat FN, et al. Aspergillus tumigatus stimulates leukocyte adhesion molecules and cytokine production by endothelial cells in vitro and during invasive pulmonary disease. Infect lmmun, 2008, 76:3429-3438. 被引量:1

二级参考文献37

  • 1赵弋清,罗霞,陈东辉,余梦瑶,杨志荣.不同剂量环磷酰胺诱导正常小鼠免疫抑制的对比研究[J].免疫学杂志,2005,21(B06):122-124. 被引量:82
  • 2黄琼,李志,黄建康,杨杏芬,黄俊明,蔡玟.CD69^+/NKG2D^+比值在保健食品评价中应用[J].中国公共卫生,2005,21(9):1095-1096. 被引量:4
  • 3沈玉光,许金良,杨宗林,赵婷茹.流式细胞术测肺癌患者外周血T细胞亚群及其与临床病理的关系[J].实用诊断与治疗杂志,2006,20(2):101-102. 被引量:22
  • 4Andes D, Marchillo K, Stamstad T, et al. In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model[J]. Antimicrob Agents Chemother, 2003, 47(10): 3165 - 3169. 被引量:1
  • 5Aneds D M, van Ogtrop M. Characterization and quantitation of the qharmacodynamics of fluconazole in a neutropenic murine disseminated candidiasis infection model [J]. Antimicrob Agents Chemother, 1999, 43(9): 2116-2120. 被引量:1
  • 6Andes D, Craig W A. Animal model pharmacokinetics and pharmacodynamics: a critical review[J]. Int J Antimicrob Agent, 2002, 19(4):261-268. 被引量:1
  • 7Andes D, Marchillo K, Conklin R, et al. Pharmacodynamies of a new triazole, posaconazole, in a routine modal of disseminated eandidiasis[J]. Antimicrob Agents Chemother, 2004, 48 (1): 137 -142. 被引量:1
  • 8Andes D, Marchillo K, Stamstad T, et al. In vivo pharmacodynamics of a new triazole, ravuconazole, in a murine candidiasis model[J]. Antimicrob Agents Chemother, 2003, 47 (4): 1193 - 1199. 被引量:1
  • 9Lewis R E, Prince R A, Chi J D, et al. Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis[J]. Antimicrob Agents Chemother, 2002, 46(10): 3208 - 3214. 被引量:1
  • 10Tansho S, Abe S, Ishibashi H, et al. Efficacy of intravenous itraconazole against invasive pulmonary aspergillosis in neutropenic mice[J]. J Infect Chemother, 2006,12(6): 355 - 362. 被引量:1

共引文献166

同被引文献25

  • 1李军,郑文辉,席丽艳,林广云,李希清,鲁长明.实验大鼠侵袭性肺曲霉病早期诊断的研究[J].中华检验医学杂志,2005,28(9):943-946. 被引量:2
  • 2施毅.重视侵袭性肺部真菌感染的诊治[J].医学研究生学报,2007,20(3):225-228. 被引量:21
  • 3Groll AH,Shah PM,Mentzel C,et al.Trends in the postmortemepidemiology of invasive fungal infections at a university hospital[J].J Infect,1996,33(1):23-32. 被引量:1
  • 4Yang W,Johnston KP,Williams RO.Comparison of bioavail-ability of amorphous versus crystalline itraconazole nanoparticlesvia pulmonary administration in rats[J].Eur J Pharm Biop-harm,2010,75(1):33-41. 被引量:1
  • 5Tolman JA,Nelson NA,Bosselmann S,et al.Dose tolerabilityof chronically inhaled voriconazole solution in rodents[J].Int JPharm,2009,379(1):25-31. 被引量:1
  • 6Ho KM,Duff O,Chambers D,et al.Meta-analysis of nebulizedamphotericin B to prevent or treat pulmonary aspergillosis in im-munosuppressed animals[J].Transpl Infect Dis,2008,10(3):168-176. 被引量:1
  • 7Gavalda J,Martin MT,Lopez P,et al.Efficacy of nebulized li-posomal amphotericin B in treatment of experimental pulmonaryaspergillosis[J].Antimicrob Agents Chemother,2005,49(7):3028-3030. 被引量:1
  • 8吕沛华,赵蓓蕾,施毅,文昱婷.侵袭性肺部真菌感染动物模型制作及血浆β-葡聚糖检测的诊断价值[J].中华医院感染学杂志,2007,17(11):1328-1331. 被引量:32
  • 9Lass-Flrl C,Roilides E,Lffler J,et al.Minireview:host defence in invasive aspergillosis[J].Mycoses,2013,56(4):403-413. 被引量:1
  • 10Hartigan AJ,Westwick J,Jarai G,et al.CCR7 Deficiency on Dendritic Cells Enhances Fungal Clearance in Murine Model of Pulmonary Invasive Aspergillosis[J].J Immunol,2009,183(8):5171-5179. 被引量:1

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部